Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
And it is not just perfect for pizza, you can reheat croissants for your sweet breakfast or bake pies, biscuits and pastries directly on the refractory stone.
Source: https://www.manchestereveningnews.co.uk/news/money-saving/amazon-slashes-price-3-minute-27886549
At data cutoff, 65.4 percent of responders remained on therapy (63.6 percent and 61.5 percent who were anti-CD38 exposed or refractory, respectively).
However, Merck defended its drug, insisting that the data demonstrated significant clinical benefits for adults with refractory or unexplained chronic cough.
I don't have the details of specific types of markers we're looking at in these specific indications, but they're all very much in the relapse refractory setting.
Our data support the strategy of early combined use the ECMO to treat severe ARDS for acute respiratory distress syndrome and refractory lung failure and is a prime example of our hit early hit heart treatment philosophy.
Our ISAC platform brings a novel mechanism with the potential to address refractory and recurrent disease to the treatment of HER2+ cancers and BDC-1001 has demonstrated promise.
Rigel Pharma has 2 FDA-approved drugs: Tavalisse for chronic immune thrombocytopenia (ITP) and Rezlidhia for relapsed or refractory AML with susceptible IDH1 mutation.
Seven Refractories, the Divača-based maker of refractory concrete and plugs for blast furnaces, will get a new owner in RHI Magnesita, the Austrian producer of refractory materials, in a deal reportedly valued at €93 million.
Source: https://sloveniatimes.com/refractory-concrete-maker-acquired-in-reported-e93m-deal/
Seven Refractories, the Divača-based maker of refractory concrete and plugs for blast furnaces, will get a new owner in RHI Magnesita, the Austrian producer of refractory materials, in a deal reportedly valued at €93 million.
Source: https://sloveniatimes.com/refractory-concrete-maker-acquired-in-reported-e93m-deal/
The key value proposition of Ensifentrine is that it has a novel mechanism that can offer additional therapeutic options for patients who are refractory on bronchodilators and steroids.
Turning to Slide 14, our GPRC5D targeting CAR-T is a potential first-in-class agent in relapse or refractory multiple myeloma.